Betamethasone Dipropionate Lotion USP — Class II drug recall D-0297-2022
Terminated recall by Teligent Pharma, Inc., reported 2022-01-05, distributed nationwide. Failed Stability Specifications: lot did not meet specification for the Active Pharmaceutical Ingredient (API)
| Recall number | D-0297-2022 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teligent Pharma, Inc., Buena, NJ, United States |
| Recall initiated | 2021-08-23 |
| Classified | 2021-12-28 |
| Reported by FDA | 2022-01-05 |
| Terminated | 2024-08-16 |
| Distributed | Nationwide (US) |
| Quantity | 3,792 bottles |
| Reason classes | specification failure |
| NDC | 52565-0023-29 |
| Lot numbers | 16569 |
| Expiration dates | 2022-09 |
Product
Betamethasone Dipropionate Lotion USP, 0.05% (Augmented), 30 mL bottle, (29 g), Rx Only, Teligent Pharma Inc., Buena, NJ, 08310, NDC 52565-023-29
Reason for recall
Failed Stability Specifications: lot did not meet specification for the Active Pharmaceutical Ingredient (API) particle test, which was determined through routine stability testing
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0297-2022. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.